Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H32O8 |
| Molecular Weight | 424.4847 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CC(=O)OCC1=CO[C@@H](OC(=O)CC(C)C)[C@H]2[C@@H]1C[C@H](OC(C)=O)[C@]23CO3
InChI
InChIKey=PHHROXLDZHUIGO-PNBTUHDLSA-N
InChI=1S/C22H32O8/c1-12(2)6-18(24)26-9-15-10-27-21(30-19(25)7-13(3)4)20-16(15)8-17(29-14(5)23)22(20)11-28-22/h10,12-13,16-17,20-21H,6-9,11H2,1-5H3/t16-,17+,20-,21+,22-/m1/s1
| Molecular Formula | C22H32O8 |
| Molecular Weight | 424.4847 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: ISBN-13: 978-0895298645Curator's Comment: description was created based on several sources, including http://customers.hbci.com/~wenonah/new/nieper.htm
Sources: ISBN-13: 978-0895298645
Curator's Comment: description was created based on several sources, including http://customers.hbci.com/~wenonah/new/nieper.htm
Didrovaltrate is an active compound derived from Valeriana plant. In experiments with rat HTC cells, didrovaltrate showed considerable cytotoxicity which made it a promising agent for the treatment of cancer. There are no clinical trials available on the drug, however, there are studies reporting its clinical use (under the name Valmane) in patients with kidney cancer, oral cavity cancer, breast cancer and lung cancer. It is believed that the drugs acts by inhibiting the protein synthesis. The current marketing status of the drug is unknown and supposed to be "discontinued".
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | VALMANE Approved UseUnknown Launch Date1983 |
|||
| Primary | VALMANE Approved UseUnknown Launch Date1983 |
|||
| Primary | VALMANE Approved UseUnknown Launch Date1983 |
|||
| Primary | VALMANE Approved UseUnknown Launch Date1983 |
|||
| Primary | VALMANE Approved UseUnknown Launch Date1983 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of didrovaltrate on I-calcium current in rabbit ventricular myocytes. | 2012-09 |
|
| Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal. | 1994-08-01 |
|
| High-yield production of valepotriates by hairy root cultures of Valeriana officnalis L. var. sambucifolia Mikan. | 1992-07 |
|
| Valerian-derived sedative agents. I. On the structure and spectral assignment of the constituents of valmane using the selective INEPT nuclear magnetic resonance technique. | 1991-09 |
|
| Effects of thiol compounds versus the cytotoxicity of valepotriates on cultured hepatoma cells. | 1990-04 |
|
| The Structure of New Valepotriates from Tissue Cultures of Valeriana wallichii. | 1984-06 |
|
| [The synthesis of valperinol and various 3-aminomethyl derivatives of 2,9-dioxatricyclo[4,3,1,0(3,7)]decane from didrovaltrate]. | 1984 |
|
| Valepotriate content in different in vitro cultures of Valerianaceae and characterization of Valeriana officinalis L. callus during a growth period. | 1983-10-21 |
|
| Antispasmodic effects of valeriana compounds: an in-vivo and in-vitro study on the guinea-pig ileum. | 1982-06 |
|
| HPCL Separation and quantitative determination of valepotriates from Valeriana kilimandascharica. | 1981-10 |
|
| [In vitro- and vivo-metabolism of 14C-didrovaltrate (author's transl)]. | 1980-04 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2353067
HTC cells (rat cultured hepatoma cells) were incubated in 75 ml culture flasks at 37 C. After reacjing a density of 8*10(5) cells/ml (3-4 days), cells were treated with etanol solution of didrovaltrate (50 ul per 75 ml of culture flasks).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:32:26 GMT 2025
by
admin
on
Mon Mar 31 18:32:26 GMT 2025
|
| Record UNII |
KEN63D125F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29756
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80171363
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
242-175-8
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
CHEMBL550227
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
2200
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
KEN63D125F
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
18296-45-2
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
100000082942
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
335756
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
65689
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
SUB07105MIG
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
C024750
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY | |||
|
C77251
Created by
admin on Mon Mar 31 18:32:26 GMT 2025 , Edited by admin on Mon Mar 31 18:32:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
CONSTITUENT ALWAYS PRESENT -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |